LONDON – Owkin Inc. added a further $18 million to its series A, bringing the amount raised in the round to $70 million and equipping the company to push forward with its federated learning approach to applying artificial intelligence (AI) to the analysis of health data.

Startup Nanodiagnostics Inc. has been working for years toward a panel of point-of-care tests, helmed by one for traumatic brain injury.